Recently Viewed
empty-cart

There are no Recent Items

Close
Login/Register

Close
Single User License Price USD 125
Single User License Price INR 8750
Corporate User License Price USD 375
Corporate User License Price INR 26250
Site License Price USD 250
Site License Price INR 17500
Request a Quote

Report Title

Trovagene Inc (TROV)-Financial and Strategic SWOT Analysis Review

Quote Request for License Type
License Type Price  
Single User License USD 125
Site License USD 250
Enterprise Wide License USD 375
"Thanks for submitting the form. Our marketing team will connect back to you for the budget constraint."
Close
REQUEST A CUSTOMIZED RESEARCH

Report Title

Trovagene Inc (TROV)-Financial and Strategic SWOT Analysis Review


Quote Request for License Type
License Type Price  
Single User License USD 125
"Thanks for letting us know your requirement. Our research team will connect back to you for the bespoke requirement."
Close
REQUEST FOR SAMPLE REPORT

Report Title

Trovagene Inc (TROV)-Financial and Strategic SWOT Analysis Review

"Thanks for submitting the form. The concerned team will send the sample report in the next 12 hours."
"Thank you for downloading the sample report."
Close

Trovagene Inc (TROV)-Financial and Strategic SWOT Analysis Review



Executive Summary

Trovagene Inc (TROV)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

Business description-A detailed description of the company's operations and business divisions.

Corporate strategy-Analyst's summarization of the company's business strategy.

SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

Company history-Progression of key events associated with the company.

Major products and services-A list of major products, services and brands of the company.

Key competitors-A list of key competitors to the company.

Key employees-A list of the key executives of the company.

Executive biographies-A brief summary of the executives' employment history.

Key operational heads-A list of personnel heading key departments/functions.

Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

Key manufacturing facilities-A list of key manufacturing facilities of the company.

Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Trovagene Inc (Trovagene) is a development stage molecular diagnostic company focusing on the development and commercialization of proprietary diagnostic technologies for screening and monitoring cancer and other diseases. Its product portfolio includes liquid biopsy tests that provide important clinical information about mutations associated with common solid tumor cancers such as colorectal, melanoma, pancreas and lung cancer. These tests are used by physicians, third party clinical laboratories and pharmaceutical companies. Trovagene uses its proprietary Precision Cancer Monitoring (PCM) technology to detect and monitor circulating tumor DNA (ctDNA) in urine and blood for the detection and quantitation of oncogene mutations and improvement in cancer care. Trovagene is headquartered in San Diego, California, the US.

Trovagene Inc Key Recent Developments

Apr 13,2017: Trovagene Announces the Addition of Dr. Sandra Silberman to its Clinical Advisory Board

Mar 15,2017: Trovagene Reports Fourth Quarter and Year End 2016 Financial Results

Jan 12,2017: Trovagene Announces Broadening Network of Commercial Distributors

Dec 13,2016: Trovagene announces a reorganization to accelerate global distribution of liquid biopsy technology

Nov 09,2016: Trovagene Reports Third Quarter 2016 Financial Results and Accomplishments

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

Section 1-About the Company 6

Trovagene Inc-Key Facts 6

Trovagene Inc-Key Employees 7

Trovagene Inc-Key Employee Biographies 8

Trovagene Inc-Major Products and Services 9

Trovagene Inc-Medical Equipment Pipeline Products Data 10

Trovagene Inc Pipeline Products by Equipment Type 10

Trovagene Inc Pipeline Products by Development Stage 11

Trovagene Inc-History 14

Trovagene Inc-Company Statement 17

Trovagene Inc-Locations And Subsidiaries 19

Head Office 19

Other Locations & Subsidiaries 19

Section 2-Company Analysis 20

Trovagene Inc-Business Description 20

Trovagene Inc-Corporate Strategy 21

Trovagene Inc-SWOT Analysis 22

SWOT Analysis-Overview 22

Trovagene Inc-Strengths 22

Trovagene Inc-Weaknesses 23

Trovagene Inc-Opportunities 24

Trovagene Inc-Threats 25

Trovagene Inc-Key Competitors 26

Section 3-Company Financial Ratios 27

Financial Ratios-Capital Market Ratios 27

Financial Ratios-Annual Ratios 28

Performance Chart 30

Financial Performance 30

Financial Ratios-Interim Ratios 31

Financial Ratios-Ratio Charts 32

Section 4-Company's Lifesciences Financial Deals and Alliances 33

Trovagene Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 33

Trovagene Inc, Medical Equipment, Deals By Type, 2011 to YTD 2017 34

Trovagene Inc, Recent Deals Summary 35

Section 5-Company's Recent Developments 36

Apr 13, 2017: Trovagene Announces the Addition of Dr. Sandra Silberman to its Clinical Advisory Board 36

Mar 15, 2017: Trovagene Reports Fourth Quarter and Year End 2016 Financial Results 38

Jan 12, 2017: Trovagene Announces Broadening Network of Commercial Distributors 39

Dec 13, 2016: Trovagene announces a reorganization to accelerate global distribution of liquid biopsy technology 40

Nov 09, 2016: Trovagene Reports Third Quarter 2016 Financial Results and Accomplishments 41

Sep 09, 2016: Trovagene to Present at the 3rd Annual Precision Medicine Congress 43

Aug 18, 2016: Blue Cross Blue Shield Illinois to cover Trovera liquid biopsy tests 44

Aug 17, 2016: BCBS Illinois expands patient access to Trovera tests for 8.1 million covered lives 45

Aug 04, 2016: Trovagene Reports Second Quarter 2016 Financial Results and Accomplishments 46

May 19, 2016: Large Clinical Data Set in Lung Cancer Featuring Trovagene's Precision Cancer Monitoring Platform Selected for Oral Presentation at the 2016 ASCO Annual Meeting 47

Section 6-Appendix 48

Methodology 48

Ratio Definitions 48

About GlobalData 52

Contact Us 52

Disclaimer 52

To know more information on Purchase by Section, please send a mail to sales@kenresearch.com

List of Figures

Trovagene Inc Pipeline Products by Equipment Type 10

Trovagene Inc Pipeline Products by Development Stage 11

Trovagene Inc, Performance Chart (2012-2016) 30

Trovagene Inc, Ratio Charts 32

Trovagene Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 33

Trovagene Inc, Medical Equipment, Deals by Type, 2011 to YTD 2017 34

List of Tables

Trovagene Inc, Key Facts 6

Trovagene Inc, Key Employees 7

Trovagene Inc, Key Employee Biographies 8

Trovagene Inc, Major Products and Services 9

Trovagene Inc Pipeline Products by Equipment Type 10

Trovagene Inc Number of Pipeline Products by Development Stage 11

Trovagene Inc Pipeline Products Summary by Development Stage 12

Trovagene Inc, History 14

Trovagene Inc, Subsidiaries 19

Trovagene Inc, Key Competitors 26

Trovagene Inc, Ratios based on current share price 27

Trovagene Inc, Annual Ratios 28

Trovagene Inc, Annual Ratios (Cont...1) 29

Trovagene Inc, Interim Ratios 31

Trovagene Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 33

Trovagene Inc, Medical Equipment, Deals By Type, 2011 to YTD 2017 34

Trovagene Inc, Recent Deals Summary 35

Currency Codes 48

Capital Market Ratios 48

Equity Ratios 49

Profitability Ratios 49

Cost Ratios 50

Liquidity Ratios 50

Leverage Ratios 51

Efficiency Ratios 51

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Thermo Fisher Scientific Inc, Sysmex Inostics GmbH, Sequenom Inc, Illumina, Inc., Foundation Medicine Inc


Related Products in vertical
red-whiteline

RECENT VIEWED REPORTS



Sign up for newsletter

Close
Apply For Job

  • Applicant Name
  • Job Function
  • Total Experience
  • Skills
  • Email ID
  • Notice Period
  • Current CTC & Expected CTC
  • Phone Number
  • Validation
  • captcha  info-icon

    If validation code does not match, please refresh the page.

  • "Your resume has been successfully received. HR will connect you within 14 days in case your resume gets shortlisted."
Close
Download Company Brochure

  • Name
  • Email
  • Company Name
  • Select Country*
  • Phone Number
  • Validation
  •   info-icon

    If validation code does not match, please refresh the page.

Close
Engage With Us

  • Name
  • Designation
  • Email
  • Phone No.
  • Company Name
  • Company URL
  • Select Country*
  • Requirements/ Comments
  • Validation
  • captcha  info-icon

    If validation code does not match, please refresh the page.

  • "Thanks for submitting the form. The concerned team will respond to your query in the next 8-12 hours"
Close

Compare

Expand

person